Company Filing History:
Years Active: 2019
Title: Innovations of Mei-Chen Sung in Antibody-Drug Conjugates
Introduction
Mei-Chen Sung is a prominent inventor based in Milpitas, CA (US). She has made significant contributions to the field of biopharmaceuticals, particularly in the development of antibody-drug conjugates. Her innovative work focuses on enhancing the stability of drug components in these conjugates.
Latest Patents
Mei-Chen Sung holds 1 patent for her invention titled "Antibody-drug conjugates of tubulysin analogs with enhanced stability." This patent describes a drug component of an antibody-drug conjugate that exhibits unexpectedly improved stability, as defined by the specific structural formula outlined in the application.
Career Highlights
Mei-Chen Sung is currently employed at Bristol-Myers Squibb Company, where she continues to advance her research in the pharmaceutical industry. Her work has the potential to significantly impact cancer treatment and improve patient outcomes.
Collaborations
Throughout her career, Mei-Chen has collaborated with notable colleagues, including Qiang Cong and Sanjeev Gangwar. These partnerships have fostered a collaborative environment that enhances innovation and research in their field.
Conclusion
Mei-Chen Sung's contributions to the development of antibody-drug conjugates highlight her role as a leading inventor in the biopharmaceutical industry. Her innovative approaches are paving the way for more effective treatments in medicine.